Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Stability And Compatibility Of Taxol With Various Drugs During Simulated Y-Site Administration

Burn, Jin Pil, (2005) Stability And Compatibility Of Taxol With Various Drugs During Simulated Y-Site Administration. Malaysian Journal of Pharmaceutical Sciences, 3 (2). pp. 31-41. ISSN 16575-7319

[img]PDF - Registered users only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
289Kb

Official URL: http://www.pha.usm.my/pharmacy/Webpage%20journal/abstract/3.2-4.pdf

Affiliations

Chosun Nursing College, Korea.

Abstract

This study evaluates the compatibility and stability of Taxol with ondansetron, ranitidine, vancomycin and cephalosporins in 5% dextrose injection and 0.9% sodium chloride injection during simulated Y-site administration. Two stock solutions of Taxol 0.3 and 1.2 mg/mL and each
stock solutions of ondansetron 0.03, 0.1 and 0.3 mg/mL, ranitidine 0.5 and 2 mg/mL, vancomycin 1, 5 and 10 mg/mL and cephalosporins 20 mg/mL were prepared in glass bottles. Two mL of Taxal stock solution was mixed with 2 mL of each stock solution. Samples were removed at room temperature at time zero, one, two, four and 12 hours for immediate assay. Taxol concentrations were analyzed by High Performance Liquid Chromatography. All solutions were prepared in
triplicate, and each drug was assayed in duplicate. At the time of sampling assay and before any dilution, each sample was visually inspected for clarity, color and precipitation. The pH was also determined. Taxol in concentrations of 0.3 and 1.2 mg/mL was stable when mixed with either ondansetron (0.03, 0.1 or 0.3 mg/mL, as the hydrochloride salt), ranitidine (0.5 or 2.0 mg/mL, as
the hydrochloride salt), vancomycin (1, 5 or 10 mg/mL, as the hydrochloride salt) or cephalosporins 20 mg/mL and stored in glass containers for 12 hours. No precipitates, color changes, or haziness was seen. The changes in pH were minor.

Item Type:Journal
Keywords:Stability, Taxol, Ondansetron, Ranitidine, Vancomycin, Cephalosporins
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6829

ALLEN L V. & STILES, M. L. (1981) Compatibility of various admixtures with secondary additives at Y injection sites of intravenous administration sets, Part 2, American Journal of

Hospital Pharmacy, 38: 380-381.

ALLEN, L. V., LEVINSON, R. S. & PHISUTSINTHOP, D. (1977) Compatibility of various admixtures with secondary additives at Y injection sites of intravenous administration

sets, American Journal of Hospital Pharmacy, 34: 939-943.

BOYLE, D. A. & GOLDSPIEL, B R. (1998) A review of taxol administration, stability, and compatibility issues, Clinical Journal of Oncology Nursing, 2: 141-145.

BURM, J. P., CHOI, J. S. & GILL, M. A. (1994) Stability of Taxol and fluconazole during simulated Y-site administration, American Journal of Hospital Pharmacy, 51: 2704-2706.

CONNORS, K. A., AMIDON, G. L. & STELLA, V. J. (1986) Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd Ed., pp. 34-38 (New York: John Wiley).

DONEHOWER, R. C., ROWINSKY, E. K. & GROCHOW, L. B. (1987) Phase I trial of paclitaxel in patients with advanced cancer, Cancer Treatment Reports, 71: 1171-1177.

GUNDLACH, C. A., FAULKNER, T. P. & SOUNEY, P. F. (1991) Drug usage patterns in the ICU: Profile of a major metropolitan hospital and comparison with other ICUs,

Hospital Formulary, 1: 132-136.

ROWINSKY, E. K., CAZENZVE, L. A. & DONEHOWER, R. C. (1990) Paclitaxel: A novel investigational antineoplastic agent, Journal of the National Cancer Institute, 82: 1247-1253.

SAUTOU-MIRANDA, V., BRIGAS, F., VANHEERSWYNGHELS, S. & CHOPINEAU, J.(1999) Compatibility of paclitaxel in 5% glucose solution with ECOFLAC low-density polyethylene containers-stability under different storage conditions, International Journal of Pharmaceutics, 1: 77-82.

TRISSEL, L. A. (1986) Handbook on Injectable Drugs, 4th Ed., pp. 129-132 (Bethesda: American Society of Hospital Pharmacists).

TRISSEL, L. A. & FLORA, K. P. (1988) Stability studies: Five years later, American Journal of Hospital Pharmacy, 45: 1569-1571.

TRISSEL, L. A. & BREADY, B. B. (1992) Turbidimetric assessment of the compatibility of the paclitaxel with selected other drugs during simulated Y-site injection, American Journal of Hospital Pharmacy, 49: 1716-1719.

TRISSEL, L. A. & MARTINEZ, J F (1993) Turbidimetric assessment of the compatibility of paclitaxel with 42 other drugs during simulated Y-site injection, American Journal of

Hospital Pharmacy, 50: 300-304.

TRISSEL, L. A., XU, Q. A. & GILBERT, D. L. (1998) Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions, Annals of

Pharmacotherapy, 32: 1013-1016.

VENKATARAMANAN, R., BURKART, G. J. & PTACHCINSKL R. J. (1981) Leaching of diethylhexylphthalate from polyvinyl chloride bags into intravenous cyclosporine solutions, American Journal of Hospital Pharmacy, 43: 2800-2802.

WALL, M. E. & WANI, M. C. (1977) Antineoplastic agents from plants, Annual Review of Pharmacology, 17: 117-132.

WAUGH, W. N., TRISSEL, L. A. & STELLA, V. J. (1991) Stability, compatibility and plasticizer extraction of paclitaxel (NSC-125973) injection diluted in infusion solutions and stored in various containers, American Journal of Hospital Pharmacy, 48: 1520-1524.

ZHANG, Y., XU, Q. A., TRISSEL, L. A., GILBERT, D. L. & MARTINEZ, J. F. (1997) Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in

infusion solutions, Annals of Pharmacotherapy, 31: 1465-1470.

Repository Staff Only: item control page